Evidence map›Paper›PMID 30612581›Full record

ArticleParasites & vectors2019

Rapid multiplex gene expression assays for monitoring metabolic resistance in the major malaria vector Anopheles gambiae.

Konstantinos Mavridis, Nadja Wipf, Sandrine Medves, Ignacio Erquiaga, Pie Müller, John Vontas

Abstract readValidation Study
In one paragraph

Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. mBio · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Science advances · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Konstantinos MavridisInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, 70013, Heraklion, Greece. konstantinos_mavridis@imbb.forth.gr.
Nadja WipfDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002, Basel, Switzerland.
Sandrine MedvesFast Track Diagnostics, a Siemens Healthineers Company, Esch-sur-Alzette, 4354, Luxembourg.
Ignacio ErquiagaFast Track Diagnostics, a Siemens Healthineers Company, Esch-sur-Alzette, 4354, Luxembourg.
Pie MüllerDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002, Basel, Switzerland.
John VontasInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, 70013, Heraklion, Greece. vontas@imbb.forth.gr.

Funding

European Union Horizon 2020 Framework Program 688207 DMC-MALVEC
6 · The paper itself

Abstract

backgroundMetabolic resistance of the major malaria vector Anopheles gambiae (s.l.) to insecticides is operationally significant, particularly in combination with target site resistance. However, detection of metabolic resistance is not trivial and relies on laborious bioassays, unspecific biochemical methods, or sophisticated and expensive molecular approaches using transcriptomics.

methodsRapid one-step multiplex TaqMan-probe based RT-qPCR assays were developed and optimised to measure the expression levels of genes associated with metabolic insecticide resistance in An. gambiae (s.l.). Primers and probes were designed to target the mRNA of cytochrome P450-dependent monooxygenases CYP6P3, CYP6M2, CYP9K1, CYP6P4 and CYP6Z1, and the glutathione-S-transferase GSTE2. The novel assays were validated versus gold standard methods with a range of phenotyped mosquito specimens. The assays were also tested directly on lysates of RNAlater®-preserved mosquitoes without an RNA extraction step.

resultsThe novel assays are efficient (reaction efficiencies = 95-109%), sensitive (covering a > 10.0 Ct range with R

conclusionsThe novel multiplex assays for monitoring the levels of major detoxification genes and metabolic resistance in An. gambiae (s.l.) are simple to perform, robust and rapid. They may complement current diagnostic assays to provide evidence-based and operationally relevant information for insecticide resistance management.

Indexed as

AnimalsAnophelesBiological AssayCytochrome P-450 Enzyme SystemFemaleInactivation, MetabolicInsecticide ResistanceInsecticidesInsect ProteinsMalariaMosquito VectorsMultiplex Polymerase Chain ReactionPhenotypeCytochrome P-450 Enzyme SystemInsecticidesInsect ProteinsDetoxificationGene expressionGSTEsInsecticide resistanceMetabolic resistanceMultiplex TaqMan assaysP450s

Identifiers

PMID30612581
PMCPMC6322220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.